Objective To assess the efficacy of medication review as an isolated intervention and with several co-interventions for preventing hospital readmissions in older adults.Methods Ovid MEDLINE, Embase, The Cochrane Central Register of Controlled Trials and CINAHL were searched for randomized controlled trials evaluating the effectiveness of medication review interventions with or without co-interventions to prevent hospital readmissions in hospitalized or recently discharged adults aged >= 65, until September 13, 2019. Included outcomes were "at least one all-cause hospital readmission within 30 days and at any time after discharge from the index admission."Results Twenty-five studies met the inclusion criteria. Of these, 11 studies (7,318 participants) contributed to the network meta-analysis (NMA) on all-cause hospital readmission within 30 days. Medication review in combination with (a) medication reconciliation and patient education (risk ratio (RR) 0.45; 95% confidence interval (CI) 0.26-0.80) and (b) medication reconciliation, patient education, professional education and transitional care (RR 0.64; 95% CI 0.49-0.84) were associated with a lower risk of all-cause hospital readmission compared to usual care. Medication review in isolation did not significantly influence hospital readmissions (RR 1.06; 95% CI 0.45-2.51). The NMA on all-cause hospital readmission at any time included 24 studies (11,677 participants). Medication review combined with medication reconciliation, patient education, professional education and transitional care resulted in a reduction of hospital readmissions (RR 0.82; 95% CI 0.74-0.91) compared to usual care. The quality of the studies included in this systematic review raised some concerns, mainly regarding allocation concealment, blinding and contamination.Conclusion Medication review in combination with medication reconciliation, patient education, professional education and transitional care, was associated with a lower risk of hospital readmissions compared to usual care. An effect of medication review without co-interventions was not demonstrated. Trials of higher quality are needed in this field.

Medication review interventions to reduce hospital readmissions in older people / Dautzenberg, Lauren; Bretagne, Lisa; Koek, Huiberdina L; Tsokani, Sofia; Zevgiti, Stella; Rodondi, Nicolas; Scholten, Rob J P M; Rutjes, Anne Wilhelmina Saskia; Di Nisio, Marcello; Raijmann, Renee C M A; Emmelot-Vonk, Marielle; Jennings, Emma L M; Dalleur, Olivia; Mavridis, Dimitris; Knol, Wilma. - In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. - ISSN 1532-5415. - 69:6(2021), pp. 1646-1658. [10.1111/jgs.17041]

Medication review interventions to reduce hospital readmissions in older people

Rutjes, Anne Wilhelmina Saskia
Writing – Review & Editing
;
2021-01-01

Abstract

Objective To assess the efficacy of medication review as an isolated intervention and with several co-interventions for preventing hospital readmissions in older adults.Methods Ovid MEDLINE, Embase, The Cochrane Central Register of Controlled Trials and CINAHL were searched for randomized controlled trials evaluating the effectiveness of medication review interventions with or without co-interventions to prevent hospital readmissions in hospitalized or recently discharged adults aged >= 65, until September 13, 2019. Included outcomes were "at least one all-cause hospital readmission within 30 days and at any time after discharge from the index admission."Results Twenty-five studies met the inclusion criteria. Of these, 11 studies (7,318 participants) contributed to the network meta-analysis (NMA) on all-cause hospital readmission within 30 days. Medication review in combination with (a) medication reconciliation and patient education (risk ratio (RR) 0.45; 95% confidence interval (CI) 0.26-0.80) and (b) medication reconciliation, patient education, professional education and transitional care (RR 0.64; 95% CI 0.49-0.84) were associated with a lower risk of all-cause hospital readmission compared to usual care. Medication review in isolation did not significantly influence hospital readmissions (RR 1.06; 95% CI 0.45-2.51). The NMA on all-cause hospital readmission at any time included 24 studies (11,677 participants). Medication review combined with medication reconciliation, patient education, professional education and transitional care resulted in a reduction of hospital readmissions (RR 0.82; 95% CI 0.74-0.91) compared to usual care. The quality of the studies included in this systematic review raised some concerns, mainly regarding allocation concealment, blinding and contamination.Conclusion Medication review in combination with medication reconciliation, patient education, professional education and transitional care, was associated with a lower risk of hospital readmissions compared to usual care. An effect of medication review without co-interventions was not demonstrated. Trials of higher quality are needed in this field.
69
6
1646
1658
Medication review interventions to reduce hospital readmissions in older people / Dautzenberg, Lauren; Bretagne, Lisa; Koek, Huiberdina L; Tsokani, Sofia; Zevgiti, Stella; Rodondi, Nicolas; Scholten, Rob J P M; Rutjes, Anne Wilhelmina Saskia; Di Nisio, Marcello; Raijmann, Renee C M A; Emmelot-Vonk, Marielle; Jennings, Emma L M; Dalleur, Olivia; Mavridis, Dimitris; Knol, Wilma. - In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. - ISSN 1532-5415. - 69:6(2021), pp. 1646-1658. [10.1111/jgs.17041]
Dautzenberg, Lauren; Bretagne, Lisa; Koek, Huiberdina L; Tsokani, Sofia; Zevgiti, Stella; Rodondi, Nicolas; Scholten, Rob J P M; Rutjes, Anne Wilhelmina Saskia; Di Nisio, Marcello; Raijmann, Renee C M A; Emmelot-Vonk, Marielle; Jennings, Emma L M; Dalleur, Olivia; Mavridis, Dimitris; Knol, Wilma
File in questo prodotto:
File Dimensione Formato  
J American Geriatrics Society - 2021 - Dautzenberg - Medication review interventions to reduce hospital readmissions in.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1292479
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 20
social impact